Bharat Immunologicals & Biologicals Corporation Limited (BOM:524663)

Market Cap	980.19M
Revenue (ttm)	76.50M
Net Income (ttm)	-184.83M
Shares Out	43.18M
EPS (ttm)	-4.28
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,414
Average Volume	44,066
Open	22.56
Previous Close	22.91
Day's Range	22.31 - 23.20
52-Week Range	19.00 - 35.88
Beta	1.69
RSI	48.86
Earnings Date	Apr 24, 2025

About BOM:524663

Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, engages in the manufacture and sale of pharmaceutical products in India. It offers oral polio vaccines, zinc tablets, diarrhea management kits, and BIB sweet tablets. The company was incorporated in 1989 and is based in Bulandshahr, India.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1989
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524663

Financial Performance

In 2022, BOM:524663's revenue was 446.09 million, a decrease of -43.09% compared to the previous year's 783.88 million. Losses were -166.39 million, 90.1% more than in 2021.